← Sanofi SNY
Market Price
$43.70
Market Cap
$104.85B
P/E Ratio
N/A
Revenue (FY 2025)
↑5.5% YoY
$46.72B
3-Yr CAGR: 1.0%
Net Income
↓-34.5% YoY
$38.00M
Net Margin: 0.1%
Free Cash Flow
↓-83.4% YoY
-$2.36B
FCF Yield: -2.25%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: 0.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (SNY)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $34,708.0M | — | $24,006.0M | $91.0M | — | — | — | $-2,096.0M | — | — |
| FY 2017 | $36,204.0M | +4.3% | $24,591.0M | $121.0M | +33.0% | — | — | $-1,734.0M | $-3,128.0M | — |
| FY 2018 | $35,677.0M | -1.5% | $24,242.0M | $104.0M | -14.0% | — | — | $72.0M | $-1,387.0M | +55.7% |
| FY 2019 | $37,631.0M | +5.5% | $25,655.0M | $31.0M | -70.2% | — | — | $92.0M | $-1,169.0M | +15.7% |
| FY 2020 | $37,369.0M | -0.7% | $25,212.0M | $36.0M | +16.1% | — | — | $37.0M | $-1,273.0M | -8.9% |
| FY 2021 | $39,175.0M | +4.8% | $26,920.0M | $56.0M | +55.6% | — | — | $3.0M | $-2,040.0M | -60.3% |
| FY 2022 | $45,389.0M | +15.9% | $31,694.0M | $113.0M | +101.8% | — | — | $173.0M | $-590.0M | +71.1% |
| FY 2023 | $46,444.0M | +2.3% | $32,208.0M | $36.0M | -68.1% | — | — | $547.0M | $-1,552.0M | -163.1% |
| FY 2024 | $44,286.0M | -4.6% | $31,081.0M | $58.0M | +61.1% | — | — | $447.0M | $-1,287.0M | +17.1% |
| FY 2025 | $46,716.0M | +5.5% | $33,667.0M | $38.0M | -34.5% | — | — | $331.0M | $-2,360.0M | -83.4% |
Valuation
Market Price
$43.70
Market Cap
$104.85B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
N/A
FCF Yield
-2.25%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
72.07%
Operating Margin
13.58%
Net Margin
0.08%
Return on Equity (ROE)
N/A
Return on Assets (ROA)
0.03%
Asset Turnover
0.37x
Revenue 3-Yr CAGR
0.97%
Financial Health & Liquidity
Current Ratio
0.53
Cash Ratio
N/A
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
N/A
Total Debt
N/A
Book Value / Share
N/A
Cash Flow Efficiency
Operating Cash Flow
$331.00M
Capital Expenditures (CapEx)
$2.69B
Free Cash Flow
-$2.36B
OCF / Revenue
0.71%
FCF / Revenue
-5.05%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
N/A
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$126.81B
Total Liabilities
$751.00M
Stockholders' Equity
N/A
Current Assets
$397.00M
Current Liabilities
$751.00M